Protein lactylation in myocardial ischemia-reperfusion injury: mechanisms and therapeutic potential - Top-Institutions - MDSpire

Protein lactylation in myocardial ischemia-reperfusion injury: mechanisms and therapeutic potential

  • By

  • Hang Zhan

  • Die Li

  • Jiayao He

  • Yuzhuang Hu

  • Wei Jiang

  • Jiayu Zhang

  • Wei Chen

  • Weize Xu

  • July 16, 2026

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College
    Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College

    Beijing and Shenzhen, China

    Key Differentiators

    • Cardiology

  • #2

    Xiangya Hospital, Central South University
    Xiangya Hospital, Central South University

    Changsha, Hunan, China

    Key Differentiators

    • Cardiology

Original Source(s)

Protein lactylation in myocardial ischemia-reperfusion injury: mechanisms and therapeutic potential

  • by Hang Zhan, Die Li, Jiayao He, Yuzhuang Hu, Wei Jiang, Jiayu Zhang, Wei Chen, Weize Xu

  • July 16, 2026

Related Content

Serostatus May Modify RA Activity–CV Link

Combined rheumatoid factor and anticitrullinated protein antibody status appeared to modify the association between baseline rheumatoid arthritis disease activity and subsequent cardiovascular events in an international observational cohort.

Cardiomyopathy in women with acromegaly: clinical characteristics and associated factors in a Colombian multicenter registry

FDA Approves First Oral PCSK9 Inhibitor

Merck reported placebo-adjusted LDL-C reductions of 56% and 59% at week 24 in two phase 3 CORALreef trials supporting the approval.